Mohammad Saeid Rezaee‐Zavareh

机构：Middle East Liver Disease Center · ORCID：0000-0003-0447-6607

发表论文 86 篇 · 总被引 1049 次 · h-index 18

代表论文

• Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysis (2024 · Journal of Hepatology · 被引 101)
• Novel Biomarkers for Early Detection of Hepatocellular Carcinoma (2024 · Diagnostics · 被引 37)
• A quantitative evaluation of the impact of vaccine roll-out rate and coverage on reducing deaths: insights from the first 2 years of COVID-19 epidemic in Iran (2023 · BMC Medicine · 被引 12)
• Managing hepatocellular carcinoma recurrence after liver transplantation: emerging role of immune checkpoint inhibitors (2025 · Discover Oncology · 被引 11)
• Immune-Related Adverse Events Are Associated With Improved Outcomes After Immune Checkpoint Inhibitor Treatment in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis (2025 · The American Journal of Gastroenterology · 被引 10)
• Ethnic disparities in the epidemiology, treatment, and outcome of patients with hepatocellular carcinoma in the United States (2023 · Hepatoma Research · 被引 10)